Skip to main content
. 2010 Jan 15;5(1):e8736. doi: 10.1371/journal.pone.0008736

Table 1. Baseline charactersitics of men according to prostatitis and STD history, California Men's Health Study, 2002–2006.

Prostatitis* STDs* Gonorrhea* Syphilis*
No (n = 63,613) Yes (n = 4,228) No (n = 40,720) Yes (n = 26,010) No (n = 55,347) Yes (n = 11,378) No (n = 63,499) Yes (n = 1,437)
Age mean (SD) 57.2 (6.9) 58.4 (6.7) 57.3 (7.0) 57.3 (6.7) 57.3 (7.0) 57.5 (6.6) 57.3 (6.9) 56.5 (6.7)
Race/ethnicity % African American 8.4 7.5 4.5 14.5 4.8 25.8 7.6 21.8
Asian American 9.0 4.6 11.2 4.5 9.7 3.9 8.9 6.2
Latino 16.4 14.2 15.9 16.4 15.5 18.3 15.4 22.8
White 61.3 71.4 62.9 61.3 65.1 48.6 63.5 45.0
Other 4.9 2.3 5.5 3.3 4.9 3.4 4.7 4.3
Family history of prostate cancer* % Yes 11.9 14.8 11.5 13.0 12.0 12.5 31.0 31.7
BMI % <25 kg/m2 27.4 29.5 28.1 26.5 27.7 26.1 27.3 31.6
25–30 kg/m2 46.0 47.8 46.0 46.4 46.0 47.0 46.3 42.4
>30 kg/m2 26.6 22.7 25.9 27.1 26.3 26.9 26.4 26.0
Smoking % never 43.6 44.3 46.8 38.5 46.2 31.5 44.2 35.9
current 11.1 9.0 9.9 12.6 9.9 15.8 10.6 18.4
former 45.3 46.7 43.3 49.0 43.9 52.7 45.3 45.8
Education % < = High school 19.0 13.4 18.8 17.7 17.7 21.3 17.5 22.5
Some college 21.1 20.6 21.7 20.2 21.7 18.5 21.7 18.3
Bachelor's degree 35.0 31.0 33.6 36.9 33.7 40.0 33.8 35.6
Graduate degree 25.0 35.0 26.0 25.1 26.9 20.2 27.0 23.5
Income % <$20,000 4.8 4.3 4.4 4.8 4.2 6.1 4.3 9.0
$20,000–$39,999 15.5 14.1 14.8 16.0 14.5 18.6 14.7 23.2
$40,000–$59,999 19.4 17.9 19.3 19.5 19.0 21.1 19.2 22.8
$60,000–$79,999 18.9 17.0 19.1 18.5 18.9 18.6 19.0 15.2
$80,000–$99,999 14.0 14.2 14.2 13.9 14.3 13.2 14.3 11.8
>$100,000 27.5 32.5 28.3 27.4 29.1 22.3 28.6 18.1
Kaiser California Region % Northern 53.7 52.3 54.3 52.6 54.3 50.7 54.0 47.1
Southern 46.3 47.7 45.7 47.4 45.7 49.3 46.0 52.9
Previous history of PSA testing % None 57.3 55.8 56.8 58.3 56.7 59.4 56.9 62.5
1 or 2 test 27.0 23.2 27.0 26.2 27.2 24.7 27.0 21.7
3 or more tests 15.7 21.0 16.3 15.6 16.1 16.0 16.1 15.8
History of BPH % Yes 16.4 52.8 16.0 23.3 18.6 19.8 18.7 18.3
*

Numbers do not add to 68,675 subjects due to missing responses.

History of at least number of PSA tests from baseline to follow-up period.